U.S. FDA Requirements: Sodium Polystyrene Sulfonate
Pharmaceutical / Drug Definition :
Exchanges sodium ions for potassium ions in intestine; potassium is then eliminated in feces, which decreases serum potassium level
For more information about Sodium Polystyrene Sulfonate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
